FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Xeris Biopharma Holdings, Inc. - Common Stock
(NQ:
XERS
)
10.64
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Xeris Biopharma Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
↗
December 31, 2021
Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were...
Via
Benzinga
Mid-Afternoon Market Update: Dow Rises 50 Points; Nutriband Shares Spike Higher
↗
December 31, 2021
Toward the end of trading Friday, the Dow traded up 0.14% to 36,449.17 while the NASDAQ fell 0.20% to 15,710.56. The S&P also rose, gaining 0.08% to 4,782.32. The U.S. has the...
Via
Benzinga
What 4 Analyst Ratings Have To Say About Xeris Biopharma Holdings
↗
December 31, 2021
Analysts have provided the following ratings for Xeris Biopharma Holdings (NASDAQ:
Via
Benzinga
XERS Stock Pops on Huge FDA News. Here’s What to Know.
↗
December 31, 2021
The FDA approved Xeris' Recorlev drug for certain adult patients with Cushing's syndrome, sending XERS stock higher.
Via
InvestorPlace
Mid-Day Market Update: Crude Oil Down 1%; Xeris Biopharma Shares Jump
↗
December 31, 2021
Midway through trading Friday, the Dow traded down 0.08% to 36,370.19 while the NASDAQ fell 0.07% to 15,730.21. The S&P also fell, dropping 0.02% to 4,777.65. The U.S. has the...
Via
Benzinga
21 Stocks Moving In Friday's Mid-Day Session
↗
December 31, 2021
Gainers Nutriband Inc. (NASDAQ: NTRB) shares jumped 120.2% to $8.61 after the company announced the Korean Intellectual Property Office has fully issued its patent titled "...
Via
Benzinga
4 Biggest Price Target Changes For Friday
↗
December 31, 2021
SVB Leerink boosted the price target on Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) from $6 to $8. Xeris Biopharma shares rose 18.9% to $2.89 in pre-market trading....
Via
Benzinga
Why Xeris Biopharma Shares Are Rising Today
↗
December 31, 2021
Xeris Biopharma Holdings Inc (NASDAQ: XERS) is trading higher Friday morning after the company announced U.S. Food and Drug Administration approval of Recorlev for the...
Via
Benzinga
18 Stocks Moving in Friday's Pre-Market Session
↗
December 31, 2021
Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 34.3% to $1.37 in pre-market trading after the company reported a stock repurchase program of 500,000 shares. Xeris...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Edge Lower On Final Trading Day Of 2021
↗
December 31, 2021
Pre-open movers U.S. stock futures traded slightly lower in early pre-market trade on the final trading day of 2021. The Dow Jones dropped around 90 points, snapping a six-session...
Via
Benzinga
5 Stocks To Watch For December 31, 2021
↗
December 31, 2021
Some of the stocks that may grab investor focus today are: Medalist Diversified REIT, Inc. (NASDAQ: MDRR) reported a stock repurchase program of 500,000 shares. Medalist...
Via
Benzinga
Xeris Biopharma Announces U.S. FDA Approval of Recorlev® (levoketoconazole) for the Treatment of Endogenous Hypercortisolemia in Adult Patients With Cushing’s Syndrome
December 30, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
5 Beaten Down Biotech Stocks That Could Bounce Big In 2022
↗
December 27, 2021
Biotech stocks remain poised to eke out modest gains for 2021 after the stellar gains of the previous year. COVID-19 drug and vaccine developers experienced volatility throughout...
Via
Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
↗
December 26, 2021
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...
Via
Benzinga
Xeris Biopharma Announces the Availability of Ogluo® in the UK Through Its Commercialization Partner, Tetris Pharma
December 16, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
41 Stocks Moving In Monday's Mid-Day Session
↗
November 15, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares climbed 87.1% to $6.64 after the company agreed to be acquired by Durational Capital Management. The company also reported Q3...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021
↗
November 17, 2021
Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:
Via
Benzinga
4 Penny Stocks Insiders Are Buying
↗
November 15, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and ...
Via
Benzinga
70 Biggest Movers From Yesterday
↗
November 16, 2021
Gainers Casper Sleep Inc. (NYSE: CSPR) shares jumped 88.5% to close at $6.69 on Monday after the company agreed to be acquired by Durational Capital Management. The...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
November 15, 2021
Welcome back, trader! We're getting right into the thick of it this week with a look at the biggest pre-market stock movers for Monday!
Via
InvestorPlace
20 Stocks Moving in Monday's Pre-Market Session
↗
November 15, 2021
Gainers Creative Realities, Inc. (NASDAQ: CREX) rose 132.9% to $3.40 in pre-market trading as the company reported a merger with Reflect Systems on Friday. Bit Brother Limited (...
Via
Benzinga
Xeris Biopharma Reports Third Quarter 2021 Financial Results and Other Highlights
November 10, 2021
From
Xeris Pharmaceuticals, Inc.
Via
Business Wire
Xeris Biopharma to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 10, 2021
November 02, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
Why Xeris Pharmaceuticals Is Soaring 7% Higher Today
↗
October 29, 2021
The biopharma is starting to put together a string of good news advances.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021
↗
October 29, 2021
Upgrades For Preferred Bank (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 25, 2021
Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
October 25, 2021
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 28.64% to $2.47 during Monday's pre-market session. The company's market cap stands at $38.1 million....
Via
Benzinga
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
October 25, 2021
From
Xeris Biopharma Holdings, Inc.
Via
Business Wire
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
↗
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
↗
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
